Connection

Marc Chimowitz to Constriction, Pathologic

Back to Details
This is a "connection" page, showing publications Marc Chimowitz has written about Constriction, Pathologic.
Marc Chimowitz
Connection Strength
2.267
Constriction, Pathologic
  1. 10 questions about intracranial atherosclerotic stenosis. Neurologist. 2010 Nov; 16(6):400-5.
    View in: PubMed
    Score: 0.328
  2. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
    View in: PubMed
    Score: 0.179
  3. Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis). Stroke. 2017 06; 48(6):1501-1506.
    View in: PubMed
    Score: 0.128
  4. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014; 37(6):417-22.
    View in: PubMed
    Score: 0.106
  5. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.103
  6. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.101
  7. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013 Nov; 12(11):1106-14.
    View in: PubMed
    Score: 0.101
  8. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012 Oct; 43(10):2682-8.
    View in: PubMed
    Score: 0.093
  9. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
    View in: PubMed
    Score: 0.086
  10. Treatment of atherosclerotic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):2257-61.
    View in: PubMed
    Score: 0.074
  11. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009 Mar; 40(3):719-25.
    View in: PubMed
    Score: 0.071
  12. Re: Turk et al and the "how do we spin wingspan?" commentary. AJNR Am J Neuroradiol. 2008 Sep; 29(8):e69; author reply e70.
    View in: PubMed
    Score: 0.069
  13. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008 Apr 22; 70(17):1518-24.
    View in: PubMed
    Score: 0.068
  14. Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
    View in: PubMed
    Score: 0.067
  15. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am. 2007 Aug; 17(3):355-63, viii-ix.
    View in: PubMed
    Score: 0.065
  16. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke. 2007 Jul; 38(7):2055-62.
    View in: PubMed
    Score: 0.065
  17. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Lancet Neurol. 2022 Dec; 21(12):1089-1098.
    View in: PubMed
    Score: 0.047
  18. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology. 2000 Aug 22; 55(4):465-6.
    View in: PubMed
    Score: 0.040
  19. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.036
  20. Type and Duration of Exercise in the SAMMPRIS Trial. Neurologist. 2019 Jan; 24(1):10-12.
    View in: PubMed
    Score: 0.036
  21. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.033
  22. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
    View in: PubMed
    Score: 0.029
  23. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke. 2015 Nov; 46(11):3282-4.
    View in: PubMed
    Score: 0.029
  24. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995 Aug; 45(8):1488-93.
    View in: PubMed
    Score: 0.028
  25. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.027
  26. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
    View in: PubMed
    Score: 0.023
  27. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke. 2012 May; 43(5):1230-3.
    View in: PubMed
    Score: 0.022
  28. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.021
  29. Ipsilateral leg weakness associated with carotid stenosis. Stroke. 1990 Sep; 21(9):1362-4.
    View in: PubMed
    Score: 0.020
  30. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010 Aug; 41(8):1636-40.
    View in: PubMed
    Score: 0.020
  31. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke. 2009 Jun; 40(6):1999-2003.
    View in: PubMed
    Score: 0.018
  32. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke. 2009 Feb; 40(2):505-9.
    View in: PubMed
    Score: 0.018
  33. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008 Jun; 65(6):733-7.
    View in: PubMed
    Score: 0.017
  34. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008 Mar; 39(3):1039-41.
    View in: PubMed
    Score: 0.017
  35. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.017
  36. Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
    View in: PubMed
    Score: 0.016
  37. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
    View in: PubMed
    Score: 0.016
  38. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006 Oct 10; 67(7):1275-8.
    View in: PubMed
    Score: 0.015
  39. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006 Jan 31; 113(4):555-63.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.